Glaucoma: The Silent Thief

Using Genomics to understand who is at risk and how to improve treament.

Glaucoma has been known since antiquity and is still the leading cause of blindness, affecting 60 million people worldwide. There are treaments to delay vision loss, but no cure. Genomic technologies offer insights into the causes of glaucoma and can help scientists develop better treatments.

Prof. Colin Willoughby, University of Liverpool, is an Eye Surgeon and Professor of Molecular Ophthalmology. His lab is working on the genetic basis of glaucoma and developing new molecular and stem cell therapies to tackle this devastating condition.

Registration required.

See What's On in Liverpool